Royal Bank of Canada
TMDX icon

Royal Bank of Canada’s Transmedics TMDX Stock Holding History

Royal Bank of Canada’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Sell
26,937
-35,896
-57% -$4.68M ﹤0.01% 2877
2025
Q4 		$7.64M Sell
62,833
-135,609
-68% -$17M ﹤0.01% 2132
2025
Q3 		$22.3M Sell
198,442
-102,227
-34% -$12M ﹤0.01% 1563
2025
Q2 		$40.3M Buy
300,669
+274,087
+1,031% +$30.1M 0.01% 1063
2025
Q1 		$1.79M Buy
26,582
+8,604
+48% +$592K ﹤0.01% 3022
2024
Q4 		$1.12M Sell
17,978
-2,436
-12% -$227K ﹤0.01% 3449
2024
Q3 		$3.2M Buy
20,414
+1,156
+6% +$178K ﹤0.01% 2633
2024
Q2 		$2.9M Buy
19,258
+9,533
+98% +$1.14M ﹤0.01% 2615
2024
Q1 		$718K Sell
9,725
-17,134
-64% -$1.41M ﹤0.01% 3716
2023
Q4 		$2.12M Buy
26,859
+420
+2% +$25.3K ﹤0.01% 3034
2023
Q3 		$1.45M Buy
26,439
+3,166
+14% +$228K ﹤0.01% 3125
2023
Q2 		$1.96M Buy
23,273
+5,622
+32% +$430K ﹤0.01% 2854
2023
Q1 		$1.34M Buy
17,651
+13,071
+285% +$904K ﹤0.01% 3130
2022
Q4 		$283K Buy
4,580
+3,458
+308% +$184K ﹤0.01% 4584
2022
Q3 		$46K Buy
1,122
+971
+643% +$42.2K ﹤0.01% 5785
2022
Q2 		$5K Sell
151
-1,441
-91% -$38.4K ﹤0.01% 6667
2022
Q1 		$43K Sell
1,592
-3,553
-69% -$63.7K ﹤0.01% 6189
2021
Q4 		$98K Buy
5,145
+2,129
+71% +$53.4K ﹤0.01% 5964
2021
Q3 		$100K Sell
3,016
-1,302
-30% -$39.8K ﹤0.01% 5704
2021
Q2 		$144K Buy
4,318
+2,579
+148% +$71.5K ﹤0.01% 5345
2021
Q1 		$72K Buy
1,739
+1,387
+394% +$42.7K ﹤0.01% 5662
2020
Q4 		$7K Buy
352
+315
+851% +$4.66K ﹤0.01% 6543
2020
Q3 		$1K Buy
37
+14
+61% +$240 ﹤0.01% 6482
2020
Q2 		$0 Sell
23
-39
-63% -$610 ﹤0.01% 6905
2020
Q1 		$1K Sell
62
-953
-94% -$16K ﹤0.01% 6492
2019
Q4 		$19K Buy
+1,015
New +$18.6K ﹤0.01% 5878
2019
Q3 		– Sell
-100
Closed -$3K – 7110
2019
Q2 		$3K Buy
+100
New +$2.73K ﹤0.01% 6499

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's TMDX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Transmedics (TMDX) stake by 57% in Q1 2026, selling an estimated $4.68M and leaving 26,937 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2877.

Royal Bank of Canada first reported a position in TMDX in Q2 2019 and has held it in 27 quarters since. The position peaked at $40.3M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Royal Bank of Canada held 26,937 shares of Transmedics worth $2.68M as of Q1 2026.
  • Royal Bank of Canada sold 35,896 Transmedics shares in Q1 2026, an estimated $4.68M.
  • Transmedics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2877 holding.
  • Royal Bank of Canada first reported a position in Transmedics in Q2 2019 and has held it in 27 quarters since.
  • Royal Bank of Canada's Transmedics position peaked at $40.3M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.